Physician profile
John R Weaver
NPI 1356370795
$3,095.78
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,314 · 2020: $131 · 2021: $31.64 · 2022: $314 · 2023: $227 · 2024: $76.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $2,275.53 | 2019 | |
| Radius Health, INC. | $128.61 | 2019-2024 | Tymlos |
| Stryker Corporation | $126.03 | 2022-2023 | Crossfire |
| Amgen INC. | $109.01 | 2019-2023 | Evenity, Prolia |
| Smith+Nephew, INC. | $79.28 | 2022-2024 | Trigen Intertan, Evos, Grafix |
| Pacira Pharmaceuticals Incorporated | $74.50 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $73.82 | 2023 | Gel-One Cross-Linked Hyaluronate, Persona |
| Nevro Corp. | $54.54 | 2022 | |
| Depuy Synthes Sales INC. | $43.11 | 2023-2024 | Tfn-Advance, Na, Monovisc |
| Djo, LLC | $27.42 | 2020 | |
| Medtronic, INC. | $18.07 | 2024 | Aquamantys(Tm) |
| Horizon Therapeutics Plc | $17.96 | 2022 | |
| Sanara Medtech INC. | $16.74 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.09 | 2022 | |
| Kci USA, INC. | $12.11 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $11.60 | 2020 | |
| Dynasplint Systems INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.